ATE439877T1 - Gerollter draht zur kontrollierten freisetzung von arzneimitteln an das auge - Google Patents

Gerollter draht zur kontrollierten freisetzung von arzneimitteln an das auge

Info

Publication number
ATE439877T1
ATE439877T1 AT06762297T AT06762297T ATE439877T1 AT E439877 T1 ATE439877 T1 AT E439877T1 AT 06762297 T AT06762297 T AT 06762297T AT 06762297 T AT06762297 T AT 06762297T AT E439877 T1 ATE439877 T1 AT E439877T1
Authority
AT
Austria
Prior art keywords
eye
drug
drugs
controlled release
delivery
Prior art date
Application number
AT06762297T
Other languages
English (en)
Inventor
Aylvin Dias
Levinus Koole
Rachel Pijls
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE439877T1 publication Critical patent/ATE439877T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06762297T 2005-07-11 2006-06-30 Gerollter draht zur kontrollierten freisetzung von arzneimitteln an das auge ATE439877T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05076580 2005-07-11
EP05077210 2005-09-27
PCT/EP2006/006355 WO2007006427A1 (en) 2005-07-11 2006-06-30 Coiled wire for the controlled release of dugs to the eye

Publications (1)

Publication Number Publication Date
ATE439877T1 true ATE439877T1 (de) 2009-09-15

Family

ID=36794864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06762297T ATE439877T1 (de) 2005-07-11 2006-06-30 Gerollter draht zur kontrollierten freisetzung von arzneimitteln an das auge

Country Status (5)

Country Link
US (1) US8109913B2 (de)
EP (1) EP1912686B1 (de)
AT (1) ATE439877T1 (de)
DE (1) DE602006008632D1 (de)
WO (1) WO2007006427A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9014787B2 (en) 2009-06-01 2015-04-21 Focal Therapeutics, Inc. Bioabsorbable target for diagnostic or therapeutic procedure
US20130289389A1 (en) * 2012-04-26 2013-10-31 Focal Therapeutics Surgical implant for marking soft tissue
AU2015292332A1 (en) 2014-07-25 2017-02-16 Focal Therapeutics, Inc. Implantable devices and techniques for oncoplastic surgery
US11219502B2 (en) 2017-09-11 2022-01-11 Medtronic Advanced Energy, Llc Transformative shape-memory polymer tissue cavity marker devices, systems and deployment methods
CN111132632A (zh) 2017-09-26 2020-05-08 Devicor医疗产业收购公司 具有微球涂层的活检部位标记物
US11324567B2 (en) 2018-02-01 2022-05-10 Medtronic Advanced Energy, Llc Expandable tissue cavity marker devices, systems and deployment methods
CN114259478B (zh) * 2022-02-15 2023-08-04 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 一种花粉水凝胶杂化载药微球的制备方法及其在光热刺激下响应性释放药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5690667A (en) * 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US6478776B1 (en) * 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
DE60135352D1 (de) * 2000-08-30 2008-09-25 Univ Johns Hopkins Vorrichtung zur intraokularen wirkstoffverabreichung
CA2689598A1 (en) * 2001-05-29 2002-12-05 Microvention, Inc. Method of manufacturing expansile filamentous embolization devices
US20060024350A1 (en) * 2004-06-24 2006-02-02 Varner Signe E Biodegradable ocular devices, methods and systems

Also Published As

Publication number Publication date
EP1912686B1 (de) 2009-08-19
WO2007006427A1 (en) 2007-01-18
DE602006008632D1 (de) 2009-10-01
US8109913B2 (en) 2012-02-07
EP1912686A1 (de) 2008-04-23
US20090143747A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
EP3941399A4 (de) Implantierbare okulare arzneimittelabgabevorrichtungen und -verfahren
EP4374852A3 (de) Anti-cdh6-antikörper und anti-cdh6-antikörper-wirkstoff-konjugat
JP2014156496A5 (ja) 生分解性眼内インプラント
EP3861982A3 (de) Intrakamerales implantat zur behandlung von augenleiden
WO2011127064A3 (en) Sustained-release reservoir implants for intracameral drug delivery
MY198928A (en) B7-h3 antibody, antigen-binding fragment thereof and medical use thereof
WO2016113550A3 (en) Dressing
EP4045020A4 (de) Lipid und lipidnanopartikelformulierung zur wirkstofffreisetzung
WO2016042163A3 (en) Ophthalmic drug compositions
WO2012009684A3 (en) Drug delivery medical device
RU2015146903A (ru) Слой лекарственного покрытия
MY197845A (en) Pharmaceutical composition
WO2015106128A3 (en) Rnai agents modified at the 4'-c-position
JP2016504362A5 (de)
WO2006002366A3 (en) Biodegradable ocular devices, methods and systems
WO2014104974A3 (en) Self-assembling ultrashort peptides modified with bioactive agents by click chemistry
EP4268864A3 (de) Nasenimplantat
WO2013036309A3 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
ATE439877T1 (de) Gerollter draht zur kontrollierten freisetzung von arzneimitteln an das auge
WO2014210315A3 (en) Stents and methods of use thereof
HK1213824A1 (zh) 治疗在糖尿病患者的血管疾病的方法
EP3982929A4 (de) Hydrogel-arzneimittelabgabezusammensetzung
KR102435274B9 (ko) 약물전달시스템으로서의 안구 주입형 마이크로젤 및 이를 포함하는 하이드로젤
WO2017156078A3 (en) Delivery of nitric oxide-releasing phospholipids, liposomes, and high density lipoprotein-like nanoparticles (hdl nps) by drug eluting stents and intra-arterial injection
WO2020219823A8 (en) Intracanalicular hydrogel inserts for the delivery of anesthetics

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties